Applied Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Applied Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Applied Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$29.7M, a 92% decline year-over-year.
  • Applied Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$92.3M, a 47.6% decline year-over-year.
  • Applied Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$64.5M, a 22.2% increase from 2022.
  • Applied Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$83M, a 21.5% increase from 2021.
  • Applied Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$106M, a 11.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$64.5M +$18.4M +22.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 -$83M +$22.7M +21.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 -$106M -$11.2M -11.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$94.5M -$48.9M -107% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$45.6M -$32.1M -237% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
2018 -$13.5M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.